156 related articles for article (PubMed ID: 3904908)
1. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
Bishop MC; Selby C; Taylor M
Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
Morales A; Nickel JC
Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
[TBL] [Abstract][Full Text] [Related]
3. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
Fosså SD; Fosså J; Aakvaag A
J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
[TBL] [Abstract][Full Text] [Related]
4. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
5. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
6. Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
Daponte D; Sylvester R; De Pauw M; Fryszman A; Smith RM; Smith PH
Br J Urol; 1983 Aug; 55(4):408-12. PubMed ID: 6349745
[TBL] [Abstract][Full Text] [Related]
7. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
8. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
Daehlin L; Damber JE; von Schoultz B; Bergman B
Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
[TBL] [Abstract][Full Text] [Related]
9. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
Harper ME; Peeling WB; Cowley T; Brownsey BG; Phillips ME; Groom G; Fahmy DR; Griffiths K
Acta Endocrinol (Copenh); 1976 Feb; 81(2):409-26. PubMed ID: 946155
[TBL] [Abstract][Full Text] [Related]
10. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
11. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
12. [Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
Daponte DP; Stevens I; Robinson MR
Actas Urol Esp; 1986; 10(6):437-40. PubMed ID: 3825644
[No Abstract] [Full Text] [Related]
13. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Benson RC; Cummings K
Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
[No Abstract] [Full Text] [Related]
14. Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.
Boyns AR; Cole EN; Phillips ME; Hillier SG; Cameron EH; Griffiths K; Shahmanesh M; Feneley RC; Hartog M
Eur J Cancer (1965); 1974 Jul; 10(7):445-9. PubMed ID: 4376085
[No Abstract] [Full Text] [Related]
15. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
Kjaer TB; Nilsson T; Madsen PO
Urology; 1975 Jun; 5(6):802-4. PubMed ID: 1136096
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
[No Abstract] [Full Text] [Related]
17. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
Sandberg AA; Rosenthal H; Mittelman A; Murphy GP
Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
[TBL] [Abstract][Full Text] [Related]
18. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
Fritjofsson A; Norlén BJ; Högberg B; Rajalakshmi M; Cekan SZ; Diczfalusy E
Scand J Urol Nephrol; 1981; 15(1):37-44. PubMed ID: 6787701
[TBL] [Abstract][Full Text] [Related]
19. The EORTC Phase III trials in prostatic cancer.
Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
[No Abstract] [Full Text] [Related]
20. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
[No Abstract] [Full Text] [Related]
[Next] [New Search]